ehealth radio network
Episodes
Saturday Jun 27, 2015
Surviving Pancreatic Cancer with Larisa Belote
Saturday Jun 27, 2015
Saturday Jun 27, 2015
Larisa Belote Owner of Step by Step Wellness and author of the new book Surviving Pancreatic Cancer joins eHealth Radio and the Cancer Prevention & Nutrition Channels.
Listen to interview with host Eric Michaels & guest Larisa Belote discuss the following:Tell me about your book "Surviving Pancreatic Cancer".Why did you write this book? Did something or someone influence or inspire you here?Do you incorporate any of the therapies or treatments in your practice as a Holistic Nutritionist today that you describe in your book?What type of message do you want the listeners to walk away with today?
Duration: 14:16
Larisa Belote is an owner of Step by Step-Wellness. She is a Certified Holistic Nutritionist, CHHC, AADP, who studied at the Institute for Integrative Nutrition and completed her training with some of the world's top health and wellness experts. She is certified by the American Association of Drugless Practitioners and has obtained Continuing Education Units from Purchase College, State University of New York.
Larisa is dedicated in helping her clients find balance in all areas of their lives by making lifestyle changes that produce real and lasting results. By looking at how all areas of life are connected through mind, body and spirit, her clients develop a deeper understanding of the foods and lifestyle choices that work best for their bio-individuality that will improve their energy, balance, health and weight. Larisa leads workshops on nutrition and offers one on one as well as group health coaching in person, telephone or skype. Her office is located at 4 Bridge Plaza Drive, Manalapan NJ.
Larisa is also an author of a new book called Surviving Pancreatic Cancer.
Website: www.stepbystep-wellness.com
Friday May 08, 2015
Friday May 08, 2015
Dr. Robert Nagourney, Founder and Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and a Clinical Professor, at University of California Irvine, Department of Obstetrics and Gynecology joins eHealth Radio and the Cancer Prevention Information Channel.
Listen to interview with host Eric Michaels & guest Dr. Robert Nagourney discuss the following:Tell us about your pioneering work in personalized chemotherapy and functional profiling.Is it possible to choose the most effective chemotherapy drugs before patients receive them?Why hasn’t this been more widely applied?Do you have published data to support your work?What do you think has made it possible for you to succeed where others have failed?Going forward, what are the implications of your ability to successfully conduct these studies?What is the best advice you can give to people who have been just diagnosed with cancer?
Duration: 10:24
Robert A. Nagourney, MD, is Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and a Clinical Professor, University of California Irvine, Department of Obstetrics and Gynecology. He is board certified in internal medicine, medical oncology, and hematology.
A native of Bridgeport, Connecticut, Dr. Nagourney completed undergraduate education at Boston University, earning a BA in Chemistry, Summa Cum Laude, Phi Beta Kappa with Distinction in Biochemistry. He received his MD at McGill University in Montreal, Canada, where he was a University Scholar. After completing his residency in Internal Medicine at the University of California, Irvine, Dr. Nagourney received fellowship training in Medical Oncology at Georgetown University in Washington, DC. He went on to complete a second fellowship in hematology at the Scripps Institute in La Jolla, California, where he was the recipient of the Scripps Institute Young Investigator Award.
Dr. Nagourney went on to found Rational Therapeutics, a cancer research institute located in Long Beach, California, that has pioneered the development of “functional profiling” in human tumors. The functional profiling platform uses human tumor microspheroids in primary culture to measure drug induced programmed cell death, both apoptotic and non-apoptotic. It has proven a robust method for the prediction of clinical response to therapy. Following its successful application to cytotoxic drugs and radiation, this platform has now been successfully applied in the development of novel compounds, drug combinations and to the study of signal transduction inhibitors and “targeted” agents.
With over 20 years experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters and abstracts including publications in the Journal of Clinical Oncology, Gynecological Oncology and The Journal of National Cancer Institute. As co-investigator on national cooperative trials, Dr. Nagourney is recognized for the introduction of Platin/Gemcitabine doublets to the treatment of advanced ovarian and breast cancer. A frequently invited lecturer for numerous professional organizations and universities, Dr. Nagourney has served as a reviewer and on the editorial boards of several journals including Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Cancer Research and the Journal of Medicinal Food. Dr Nagourney resides in Long Beach, California with his wife and two sons.
Website: www.RationalTherapeutics.com
Thursday Apr 23, 2015
Why Colorado Patients are at a Higher Risk for Developing Melanoma than Most
Thursday Apr 23, 2015
Thursday Apr 23, 2015
Dr. Richard Asarch, who is board certified in dermatology and a fellow of the American College of Mohs Surgery with a full practice and medical spa in Denver, Colorado again joins eHealth Radio and the Cancer Prevention Channel.
On Tuesday, April 28th, 2015 the Melanoma Research Foundation will be honoring Dr. Asarch, with the MRF's Humanitarian Award. The MRF presents the Humanitarian Award to those in the local community who have committed to fighting melanoma through exemp-lary patient care, cutting-edged research and scientific leadership.
Listen to interview with host Eric Michaels & guest Dr. Richard Asarch discuss the following:What is Melanoma?What causes Melanoma?Can you explain Melanoma prevention and protection? Why are patients in Colorado at a higher risk for developing Melanoma? How is Melanoma detected & how is it diagnosed? You have performed over 30,000 Mohs surgeries. How does Mohs work to treat Melanoma?What are the top 3 pieces of advice you would give your patients about Melanoma and Skin Cancer?
Duration: 12:38
Dr. Richard Asarch, MD, PC heads the Asarch Center for Dermatology, Laser and Mohs Surgery in Denver, CO, and it’s accompanying state-of-the-art DermaSpa. Having spent over 35 years in practice evaluating and adopting the latest advances in medical and cosmetic dermatology, his experience and continued dedication to his patients and their overall health, Dr. Asarch is truly a leader in both the local and national medical community.
Considered an expert on melanoma and other skin cancers, Dr. Asarch is Double Board Certified in Dermatology and Dermatopathology and has successfully completed over 30,000 Mohs Surgeries for skin cancer removal. Dr. Asarch introduced Mohs to the state of Colorado in 1977 after studying directly with Dr. Frederic Mohs, the founder of Mohs Surgery.
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also provides education about prevention, diagnosis and the treatment of melanoma.
Website: www.asarchcenter.com
Thursday Mar 26, 2015
Thursday Mar 26, 2015
Danna F. Grear, MD a Clinical Breast Radiologist who has been providing imaging services in Northwest Arkansas since 1989 joins eHealth Radio and the Cancer Prevention and Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. Danna F. Grear discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination?How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue. Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 16:53
Danna F. Grear, MD is a Clinical Breast Radiologist who has been providing imaging services in Northwest Arkansas since 1989. Dr. Grear, along with Dr. Kevin Pope developed the first image guided breast biopsy program in Northwest Arkansas in 1995. She and Dr. Kevin Pope founded The Breast Center, a MANA Clinic, as the first independent, dedicated breast center in Arkansas in 2003.
Grear is board certified in Radiology by the American Board of Radiology. She completed a Diagnostic Radiology Residency at University Texas Medical Branch in Galveston, Texas. She was instrumental in the organization of the Multidisciplinary Breast Conference at Washington Regional Medical Center and currently serves on the Credentials Committee. Grear has been a member of the Mammography Clinical Image Review Committee for the Arkansas Department of Health for over 10 years. She is a current member of the Society of Breast Imaging and the American Society of Breast Disease.
Grear serves on the board for the Susan G. Komen for the Cure Ozark Affiliate and has been an active volunteer since it’s inception in 1998. She received the Komen Cameo award in 2007, a national award recognizing volunteerism. She is actively involved in the community with organizations such as Womenade. Grear serves on the MANA Charitable Fund Board and was key in creating the Murray T. Harris Allied Healthcare Scholarship program.
Websites: www.mana.md | www.sonocine.com
Tuesday Mar 17, 2015
A new advanced technology to help find early stage breast cancer
Tuesday Mar 17, 2015
Tuesday Mar 17, 2015
Dr. David Weintritt, a board certified breast surgeon and Founder of the National Breast Center with the goal of improving access to care, technology for breast cancer screening and treatment, and giving women in the Washington Metropolitan Area the options they deserve joins eHealth Radio and the Cancer Prevention and Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. David Weintritt discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination? How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue. Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 13:49
Dr. David Weintritt is a board certified breast surgeon and founder of the National Breast Center. Dr. Weintritt completed his college and medical education at the University of Florida. After graduation, he served as a general surgeon in the Air Force at Andrews Air Force Base.
During his tenure as an Air Force surgeon, he was able to work with Bethesda Naval Hospital in offering sentinel node biopsy, a procedure now standard in breast cancer surgery. From there, he entered into private practice in Annapolis, MD where he worked in the hospital’s new breast center; gaining experience in breast ultrasound and minimally invasive approaches for breast disease management.
In 2003, Dr. Weintritt opened his own practice in Alexandria, VA. He started a program for sentinel node biopsy and was the first to bring partial breast radiation to the area.
In 2010, Dr. Weintritt was named a director of the INOVA Mount Vernon Breast Care Institute. He is consistently the highest volume breast cancer surgeon in the INOVA system.
In 2012 Dr. Weintritt founded the National Breast Center to continue raising awareness of new treatment options and to expand services available for breast cancer patients.
In 2014 Dr. Weintritt founded the National Breast Center Foundation with the goal of improving access to care, technology for breast cancer screening and treatment, and giving women in the Washington Metropolitan Area the options they deserve.
Website: www.nationalbreastcenter.com | www.sonocine.com
Wednesday Mar 04, 2015
Palmetto Health Breast Center, offering ultrasound breast screening to their patients
Wednesday Mar 04, 2015
Wednesday Mar 04, 2015
Dr. Shawn Conwell, the Professional Director of Palmetto Health Breast Center in Richland, South Carolina and a Partner at Pitts Radiology joins eHealth Radio and the Cancer Prevention and Technology Channels. Listen to interview with host Eric Michaels & guest Dr. Shawn Conwell discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination? How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue. Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 15:39
Dr. W. Shawn Conwell is the Professional Director of Palmetto Health Breast Center in Richland, South Carolina and a Partner at Pitts Radiology. For over 15 years, Dr. Conwell has been helping to empower patients to get control of their health and no various medical screening options that are available to them. He is a highly coveted ‘Breast Specialist’ who graduated from Medicine College of Georgia School Of Medicine, Augusta Georgia and a residency training of Diagnostic Radiology at Metrohealth Medicine Center. He also has completed extensive post graduate training work at Women’s Imaging Fellowship, Magee Women’s Hospital, Case Western Reserve and MetroHealth Medical.
Dr. Conwell belongs to the following professional societies: American College of Radiology, Society of Breast Imaging, American Roentgen Ray Society, Radiological Society of North America and American Association for Women Radiologists. He has received numerous awards including the 2005 American College of Radiology Moorefield Fellow for Economics and Health Policy, the 2004 Resident of the Year and the 2000 Humanism in Medicine Award; Awarded by the Health Care Foundation of New Jersey.
Websites: www.palmettohealth.org | www.sonocine.com
Thursday Feb 26, 2015
Thursday Feb 26, 2015
Dr. Kevin Kelly, one of the country's leading authorities on breast cancer detection and Co-Founder of SonoCiné, Inc. joins eHealth Radio and the Cancer Prevention & Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Kevin Kelly discuss the following:Describe to our listeners what SonoCiné AWBUS is and what does AWBUS stand for?What makes SonoCiné AWBUS™ technology different?How does it work?I understand this exam is for women with dense breast tissue. What is the difference between dense-breast tissue and fatty-breast tissue?Recently it seems there has been states passing a law that are Dense Breast Tissue notification laws. What are those laws and how do they impact what your team is trying to do? Do you see ultrasound one day replacing mammography? Why has every doctor not adopted the technology yet? Where can women go to get more information or to find a doctor that performs the SonoCiné exam?
Duration: 17:05
Dr. Kevin M. Kelly is Chief Executive Officer, Chairman of the Board, Chief Medical Officer and Co-Founder of SonoCiné, Inc. He is also Medical Director of the Breast Ultrasound Center in Pasadena, CA.
Dr. Kelly is one of the country's leading authorities on breast cancer detection in women with dense-breast tissue and women with implants. He was Director of Breast Imaging at the Huntington Memorial Hospital and the Huntington Hill Breast Center, Pasadena, CA for 20 years before opening a private practice in Pasadena, CA. His breakthrough clinical study on breast cancer detection using ultrasound in radiographically dense breasts was published in 2009 in European Radiology (one of the most prestigious radiology journals in the world). This pivotal work has since been cited in more than 100 other scientific publications around the world.
Dr. Kelly's lifelong commitment to early breast cancer detection began with clinical research into the limitations of mammography in detecting and diagnosing breast cancer in dense-breasted women. In 1997, he co-founded SonoCiné, Inc., to develop and clinically validate what is now known as the SonoCiné AWBUS™ technology. Working with other leading breast imaging radiologists, more than 6,000 clinical results demonstrated a 100% increase in detection (over mammography) of invasive cancers smaller than 1cm in diameter. With this success, he moved to launch SonoCiné, Inc.
Dr. Kelly earned his Bachelor of Science degree at Georgetown University. He completed his Medical Degree, internship and first two years of residency at St. Louis University and the St. Louis University Service of St. Louis City Hospital. He was the Leo G. Rigler Center Research Fellow at UCLA from 1973 to 1974 and finished his final year of residency at the Wadsworth Veterans Administration Hospital in Los Angeles.
In addition to his many professional credentials in the field of radiology, Dr. Kelly was also a Lt. Commander in the U.S. Public Health Service.
Website: www.sonocine.com
Friday Nov 07, 2014
Friday Nov 07, 2014
Melanie Young, a Women’s Health Advocate and author of her 2nd book coming out in November "Fearless Fabulous You! Lessons on Living Life on Your Terms" joins eHealth Radio and the Health and Personal Development Channels.
After undergoing treatment for breast cancer, Melanie wrote her first book, Getting Things Off My Chest: A Survivor’s Guide to Staying Fearless & Fabulous in the Face of Breast Cancer to help newly diagnosed women stay focused and make more informed choices about their well being during and after treatment. This book received the 2014 International Book Award for Cancer Health Topics.
Listen to interview with host Eric Michaels and guest Melanie Young discuss the following: In your new book, Fearless Fabulous You!, you talk about “being stuck” after completing your own breast cancer treatment? Is this common and how did you deal with it?You outline five key paths to take to transform your life. What are they? What are same ways to turn stumbling blocks into building blocks?In your book you discuss how to “redefine happiness.” Can you elaborate?Even though your new book is a result of your own “healing journey” after cancer, you say the life lessons learned apply to everyone. In what way?What do you tell someone who can’t seem to lift themselves out of their “emotional box”?You made some significant changes in your life in the five years after your 2009 cancer diagnosis, what were they and why did you make the decision?How have those changes impacted how your live, life today and what lesson from it do you want to share with our listeners?
Duration: 18:27
Award winning author and healthy lifestyle activist, Melanie Young, announces a new book and a radio show, both entitled “Fearless Fabulous You,” with the message: “Take charge of your life by making smarter decisions, healthier choices, and embracing change with grit and grace.”
Starting September 29, Ms. Young will host “Fearless Fabulous You!” on W4WN Radio - The Women 4 Women Radio Network on Mondays, 9 p.m. E.S.T./6 p.m. P.S.T. The show will feature inspirational women who share their stories of reinvention and wellness experts covering nutrition, movement, relationships, careers and health management. The show will be available on demand at www.iHeartRadio.com, and everywhere the iHeartRadio app is available, under the Shows & Personalities section.
Young’s second book, Fearless Fabulous You- Lessons on Living Life on Your Terms, (Cedar Fort/Nov.2014/$15.99 ISBN: 9781462115440) provides inspirational insights, motivational quotes and helpful tips to empower readers to transform their lives with positive energy, actions, and attitude.
“My goal with Fearless Fabulous You! is to help people who feel stuck in their lives with insights and tips on how to recharge your mental batteries, release negative energy and embrace positive change, reconnect with your amazing talents, reframe negative situations, and reclaim life on your terms,” said Young.
Young’s first book, Getting Things Off My Chest: A Survivor’s Guide to Staying Fearless & Fabulous in the Face of Breast Cancer (Cedar Fort) received the 2014 International Book Award for cancer health topics. This detailed and spirited guide helps newly diagnosed women navigate their breast cancer journey with handy checklists, questions to ask and tips to manage treatment, side effects and well-being.
A native of Chattanooga, TN, Ms. Young recently moved from her longtime residence in Manhattan to the Hudson Valley with her husband, David Ransom. They co-host “The Connected Table® Live,” featuring guests from the world of food, beverage and hospitality. The show airs on W4CY Radio Wednesdays at 2 p.m.ES.T/11 a.m. P.S.T.
Links:
Website: www.melanieyoung.comFacebook: www.facebook.com/connectedtable
Twitter: @connectedtable
Saturday Oct 18, 2014
Saturday Oct 18, 2014
Peter Culpepper, COO and CFO of Provectus Biopharmaceuticals specializing in developing oncology and dermatology therapies joins eHealth Radio and the Pharmaceutical & Cancer Prevention Channels.
Originally used as a coal tar–derived wool dye and most commonly been used as a stain for detecting ocular conditions, PV-10 is a rose bengal formulation now in clinical trials against cancer. Now, over 230 cancer patients have been treated with PV-10, including 12 in a Phase 1 recurrent breast cancer study. The PV-10 trials are now entering Phase II and so far have shown favorable results and may prove to be an arsenal against breast cancer. Peter Culpepper is here to discuss this novel approach.
Listen to interview with host Eric Michaels and guest Peter Culpepper discuss the following:Please tell us more about rose bengal, what makes it a an effective cancer fighter?How does PV10 work against recurrent breast cancer? What has been the response so far? What other types of cancer does PV-10 treat? How long before PV10 will be available to patients both affected by breast and skin cancers? How can patients find more information about trials?
Duration: 15:42
About Provectus Biopharma
Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies. PV-10, its novel investigational drug for cancer, is designed for injection into solid tumors (intralesional administration), thereby reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver.
The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.
About Peter R. Culpepper, CPA, MBA - Chief Financial Officer, Chief Operating Officer
Pete Culpepper has spent 20 years in the financial field working for a wide range of companies and industries in the U.S. and abroad, especially high-growth startups. His experience with for-profit companies ranges from private start-ups to publicly traded, global conglomerates. He also has worked with large non-profits and a national CPA accounting firm. He led the national operating unit of a $1 billion publicly traded telecommunications company, as well as numerous operating units in Eastern Europe for a global telecommunications company. He handled the capital reporting process for a $5 billion global construction project and the formation of systems for a division that grew $150 million in revenue in two years.
Previous employers include Neptec, Inc., a privately held optical networking component manufacturer; Metromedia Companies; and PageNet, the largest wireless messaging company in the world.
Culpepper taught undergraduate and graduate business courses for the University of Phoenix Online.
He is licensed as a Certified Public Accountant in Maryland and Tennessee.
His professional affiliations include the American Institute of Certified Public Accountants, Financial Executives International and the Financial Executives Networking Group.
Culpepper holds a master's of business administration (MBA) in finance from the University of Maryland. He earned an AAS in Accounting from the Northern Virginia Community College - Annandale, Virginia. He earned a bachelor's degree in philosophy from the College of William and Mary.
Link:
www.pvct.com
Link for clinical trials of PV-10:
http://clinicaltrials.gov/ct2/results?term=Provectus
Thursday Oct 16, 2014
The Healthy Girl's Guide to Breast Cancer with Christine Egan
Thursday Oct 16, 2014
Thursday Oct 16, 2014
Christine Egan inspirational speaker and author of "The Healthy Girl's Guide to Breast Cancer" joins eHealth Radio and the Cancer Prevention and Information Channels.
Listen to interview with host Eric Michaels and guest Christine Egan discuss the following:Tell us why you decided to write the book, "The Healthy Girl's Guide to Breast Cancer?"Is the book only for people with cancer?How has your new mantra of Redefining Healthy become an extension of your book?What is one way people can Redefine Healthy today?
Duration: 10:24Christine Egan is an inspirational speaker and the author of “The Healthy Girl’s Guide to Breast Cancer.” She ran a half marathon after ending 33 radiation treatments, and a full marathon to celebrate her remission. Today she leads the #RedefiningHealthy movement -- teaching women unexpected and delightful ways to feel more alive. Christine has been featured in Yoga Journal and Today’s Woman. She has also given talks for Saucony and New Balance. She lives in Bayport, NY for her husband and three children.<
Link: TheHealthyGirlsGuides.com